Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer?

Evaluation of response to chemotherapy in colorectal cancer patients with synchronous liver metastases is important in terms of treatment management. In this Letter to the Editor, several issues in the article are discussed. For the comparison of carbohydrate antigen 19-9 (CA19-9) values referenced...

Descripción completa

Detalles Bibliográficos
Autores principales: Demirli Atici, Semra, Kamer, Erdinc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790559/
https://www.ncbi.nlm.nih.gov/pubmed/35125833
http://dx.doi.org/10.3748/wjg.v28.i4.500
_version_ 1784640042113695744
author Demirli Atici, Semra
Kamer, Erdinc
author_facet Demirli Atici, Semra
Kamer, Erdinc
author_sort Demirli Atici, Semra
collection PubMed
description Evaluation of response to chemotherapy in colorectal cancer patients with synchronous liver metastases is important in terms of treatment management. In this Letter to the Editor, several issues in the article are discussed. For the comparison of carbohydrate antigen 19-9 (CA19-9) values referenced in the study, the patient group was not matched for cancer stage. Therefore, it may be more appropriate to select and compare CA19-9 values in patients with same-stage cancer.
format Online
Article
Text
id pubmed-8790559
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-87905592022-02-04 Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer? Demirli Atici, Semra Kamer, Erdinc World J Gastroenterol Letter to the Editor Evaluation of response to chemotherapy in colorectal cancer patients with synchronous liver metastases is important in terms of treatment management. In this Letter to the Editor, several issues in the article are discussed. For the comparison of carbohydrate antigen 19-9 (CA19-9) values referenced in the study, the patient group was not matched for cancer stage. Therefore, it may be more appropriate to select and compare CA19-9 values in patients with same-stage cancer. Baishideng Publishing Group Inc 2022-01-28 2022-01-28 /pmc/articles/PMC8790559/ /pubmed/35125833 http://dx.doi.org/10.3748/wjg.v28.i4.500 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Letter to the Editor
Demirli Atici, Semra
Kamer, Erdinc
Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer?
title Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer?
title_full Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer?
title_fullStr Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer?
title_full_unstemmed Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer?
title_short Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer?
title_sort is ca19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790559/
https://www.ncbi.nlm.nih.gov/pubmed/35125833
http://dx.doi.org/10.3748/wjg.v28.i4.500
work_keys_str_mv AT demirliaticisemra isca199effectiveinpredictingchemotherapeuticresponseinpatientswithsynchronouslivermetastaseswithcolorectalcancer
AT kamererdinc isca199effectiveinpredictingchemotherapeuticresponseinpatientswithsynchronouslivermetastaseswithcolorectalcancer

Ejemplares similares